Technology · 16/10/2026

Recognize Runs 'What's the Point?' Billboard Campaign in Times Square and Downtown LA

Recognize, an Inc. 5000 employee recognition company, launched a billboard campaign in Times Square and Downtown LA, questioning the purpose of going to work and offering an answer.

Source: PR NewswireOpen original release →

Find a company or service

Business Communicator helps companies present their offer, publish updates and connect directly.

Create a company profile Explore businesses on Business Maps →

LATEST SIGNALS

Technology · 10/17/2026

Florida Southern College Honors Distinguished Alumnus Lt. Gen. Donald L. Kerrick with ROTC Building Dedication and Statewide Raider Competition

Florida Southern College dedicated its Army ROTC building to distinguished alumnus Lt. Gen. Donald L. Kerrick on October 16, 2026, as part of a statewide Raider competition.

Read summary →

Technology · 10/17/2026

Luvme Hair Highlights Versatile Wig Looks for Fall 2026

Luvme Hair is exploring various wig styles for Fall 2026, focusing on flexibility in seasonal hair styling, and is highlighting these versatile looks.

Read summary →

Technology · 10/16/2026

Huanyu Entertainment Unveils New Productions at 42e MIPCOM Cannes

Huanyu Entertainment is showcasing its global reach at the 42e MIPCOM Cannes, where AI is taking center stage, as the company expands its international presence.

Read summary →

Technology · 10/16/2026

Portuguese Cork Association Brings 'Drink Responsibly' Campaign to New York City

The association launches an experiential pedicab program to promote mindful consumption at top wine events across New York City, starting with Wine on Wheels.

Read summary →

Technology · 10/16/2026

Sudan Conflict Remains Bleak, Security Council Warned

The humanitarian crisis in Sudan continues to deteriorate without a visible breakthrough, according to Rosemary DiCarlo, Under-Secretary-General for Political and Peacebuilding Affairs, who warned the Security Council about the conflict.

Read summary →

Technology · 10/16/2026

AMCP Market Insights Findings Show Uncertainty in Biomarker Testing for ESR1-Mutated Advanced Breast Cancer as Payers Weigh Earlier Detection and a Growing Class of Targeted Therapies

The American College of Clinical Pharmacology (AMCP) has released findings on biomarker testing for ESR1-mutated advanced breast cancer, highlighting uncertainty among payers regarding earlier detection and targeted therapies.

Read summary →